Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Epirubicin”

233 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 233 results

Testing effectiveness (Phase 2)Ended earlyNCT01351038
What this trial is testing

Concurrent Induction Chemoimmunotherapy With Epirubicine, Oxaliplatin, Capecitabine and Panitumumab in KRAs Wild-type, Resectable Type II Gastric Adenocarcinoma

Who this might be right for
KRAS Wild TypeResectable Type II Gastric Adenocarcinoma
Arbeitsgemeinschaft medikamentoese Tumortherapie 43
Testing effectiveness (Phase 2)Study completedNCT00548899
What this trial is testing

Neoadjuvant Chemotherapy Including Sorafenib in Women With Previously Untreated Primary Breast Cancer

Who this might be right for
Breast Cancer
GBG Forschungs GmbH 36
Testing effectiveness (Phase 2)Study completedNCT00375999
What this trial is testing

Docetaxel and Epirubicin in Advanced Gastric Cancer

Who this might be right for
Stomach Neoplasms
Yonsei University 34
Testing effectiveness (Phase 2)UnknownNCT02177552
What this trial is testing

Study Assessing the Effects of Chemotherapy in Advanced Esophagogastric Adenocarcinoma

Who this might be right for
Esophageal NeoplasmsStomach Neoplasms
Rigshospitalet, Denmark 98
Testing effectiveness (Phase 2)Study completedNCT00066443
What this trial is testing

Epirubicin, Docetaxel, and Pegfilgrastim in Treating Women With Locally Advanced or Inflammatory Breast Cancer

Who this might be right for
Breast Cancer
NCIC Clinical Trials Group 93
Post-approval studies (Phase 4)Not Yet RecruitingNCT04137640
What this trial is testing

Palbociclib + Letrozole Versus Epirubicin + Cyclophosphamide and Sequential Docetaxel as Neoadjuvant Chemotherapy

Who this might be right for
Breast Cancer
Shengjing Hospital 152
Not applicableStudy completedNCT03983096
What this trial is testing

Pegylated Liposomal Doxorubicin or Epirubicin in Neoadjuvant or Adjuvant Chemotherapy for Breast Cancer.

Who this might be right for
Breast Cancer
Tianjin Medical University Cancer Institute and Hospital 1,213
Testing effectiveness (Phase 2)Study completedNCT01593020
What this trial is testing

Neoadjuvant Study of Sequential Eribulin Followed by FAC Compared to Sequential Paclitaxel Followed by FEC in Early Stage Breast Cancer Not Overexpressing HER-2

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 54
Testing effectiveness (Phase 2)Ended earlyNCT00176488
What this trial is testing

Epirubicin and Vinorelbine in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer

Who this might be right for
Breast Cancer
University of Medicine and Dentistry of New Jersey 31
Testing effectiveness (Phase 2)Ended earlyNCT00193024
What this trial is testing

Epirubicin and Docetaxel in the Treatment of Patients With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
SCRI Development Innovations, LLC 90
Large-scale testing (Phase 3)Study completedNCT02450058
What this trial is testing

Adjuvant FEC Versus EP in Breast Cancer (MIG5)

Who this might be right for
Breast CancerChemotherapy, Adjuvant
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy 1,055
Testing effectiveness (Phase 2)UnknownNCT04809779
What this trial is testing

PD-1 Inhibitor Concurrent With Chemotherapy as Neoadjuvant Therapy for TNBC

Who this might be right for
Triple Negative Breast Cancer
First Affiliated Hospital, Sun Yat-Sen University 49
Early research (Phase 1)Study completedNCT00486356
What this trial is testing

Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerGastric Cancer+2 more
University of Nebraska 46
Not applicableUnknownNCT02716961
What this trial is testing

Transurethral Resection of Bladder Tumor (TURBT) Combined With Adjuvant Intravenous GC Chemotherapy for Non-muscle-invasive Bladder Cancer

Who this might be right for
Bladder CancerGemcitabine and Cisplatin ChemotherapyEpirubicin Instillation+2 more
The First Affiliated Hospital with Nanjing Medical University 208
Testing effectiveness (Phase 2)Ended earlyNCT00198172
What this trial is testing

Phase II Study of Cisplatin Plus Epirubicin Salvage Chemo in Refractory Germ Cell Tumors

Who this might be right for
Germ Cell Tumor
Indiana University School of Medicine 37
Testing effectiveness (Phase 2)UnknownNCT01428414
What this trial is testing

Efficacy and Safety Study of Trastuzumab and Paclitaxel Based Regimens to Treat HER2-positive Breast Cancer

Who this might be right for
HER-2 Positive Breast Cancer
Zhimin Shao 100
Testing effectiveness (Phase 2)Study completedNCT00110695
What this trial is testing

Therapy With Abraxane and 5-Fluorouracil, Epirubicin, Cyclophosphamide (FEC) for Patients With Breast Cancer

Who this might be right for
Breast Neoplasms
NSABP Foundation Inc 66
Large-scale testing (Phase 3)UnknownNCT01479036
What this trial is testing

Trial of Neoadjuvant Endostar, Docetaxel and Epirubicin for Patients With Breast Cancer

Who this might be right for
Breast Cancer
Xijing Hospital 800
Testing effectiveness (Phase 2)UnknownNCT02842099
What this trial is testing

Standard Chemotherapy Followed by Capecitabine as Prolonged Postoperative Adjuvant Treatment for Breast Cancer

Who this might be right for
Breast Cancer
Peking Union Medical College Hospital 500
Large-scale testing (Phase 3)Study completedNCT00309556
What this trial is testing

Randomized Neoadjuvant Study of Epirubicin and Docetaxel With/Without Capecitabine in Early Breast Cancer

Who this might be right for
Breast Cancer
Austrian Breast & Colorectal Cancer Study Group 536
Load More Results